Research Insight

Pharmaceutical companies are radically redesigning portfolio strategies to survive a "triple threat" environment of scientific complexity, regulatory upheaval like the IRA, and capital scarcity. This analysis explores the shift from efficiency-driven models to resilience-first frameworks, detailing how leaders are embedding optionality into pipelines, embracing modality agnosticism, and using dynamic resource allocation to thrive amidst volatility.

Indero is proud to announce the successful completion of an internally funded study that introduces a novel approach to evaluating topical new chemical entities (NCE) in early-phase clinical research. This innovative method leverages quantitative gene expression analysis to assess...

AI tools are boosting productivity, but researchers raise concerns about trust and transparency in answers, representing a missed opportunity for R&D In its latest report, Researcher of the Future, Elsevier reveals that one-third (33%) of corporate researchers do not yet use...

Biopharmaceutical Formulation Challenges and Stability Solutions The biopharmaceutical revolution has fundamentally transformed therapeutic medicine, with protein-based therapeutics including monoclonal antibodies, fusion proteins, antibody-drug conjugates, and advanced biologic systems becoming cornerstones of treatment for cancer, autoimmune diseases, metabolic disorders, and numerous...

Overcoming Scale Up Bottlenecks in Cell Culture and Downstream Processing In the rapidly evolving landscape of biopharmaceutical manufacturing, the journey from laboratory-scale success to commercial production represents one of the most challenging phases in bringing life-saving therapies to patients. Scale...

Partnership delivers global, end-to-end solutions to accelerate genomics research Sapio Sciences, the science-awareTM lab informatics platform, today announced a strategic partnership with Ultima Genomics. The collaboration will make multi-omics workflows more accessible and streamlined for researchers by integrating Sapio’s AI-powered lab informatics...

A Drug Master File (DMF) is a confidential regulatory submission that provides comprehensive, precise, and accurate data about an Active Pharmaceutical Ingredient (API) or a Finished Product Dosage Form (FP). It encompasses critical information on the manufacturing process, quality...